Replies to post #18399 on Intellect Neurosciences Inc. (fka ILNS)

[James salmon]

No not saying that, just that stock promotion was not done by Intellect. So theory that they did this to issue more stock is incorrect.

Look at AXON 1.6 billion plus market cap with previously failed drug. If you can see risk v reward in Intellect then you are just Here to bash, no more than that.